Annual long term liabilities:
$264.65M+$149.28M(+129.40%)Summary
- As of today (June 23, 2025), TGTX annual total long term liabilities is $264.65 million, with the most recent change of +$149.28 million (+129.40%) on December 31, 2024.
- During the last 3 years, TGTX annual long term liabilities has risen by +$187.56 million (+243.29%).
- TGTX annual long term liabilities is now at all-time high.
Performance
TGTX Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$259.19M-$5.46M(-2.06%)Summary
- As of today (June 23, 2025), TGTX quarterly total long term liabilities is $259.19 million, with the most recent change of -$5.46 million (-2.06%) on March 1, 2025.
- Over the past year, TGTX quarterly long term liabilities has increased by +$145.66 million (+128.30%).
- TGTX quarterly long term liabilities is now -3.55% below its all-time high of $268.74 million, reached on September 30, 2024.
Performance
TGTX quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
TGTX Long term liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +129.4% | +128.3% |
3 y3 years | +243.3% | +232.4% |
5 y5 years | +562.5% | +546.6% |
TGTX Long term liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +243.3% | -3.5% | +232.4% |
5 y | 5-year | at high | +1312.3% | -3.5% | +2365.0% |
alltime | all time | at high | >+9999.0% | -3.5% | >+9999.0% |
TGTX Long term liabilities History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $259.19M(-2.1%) |
Dec 2024 | $264.65M(+129.4%) | $264.65M(-1.5%) |
Sep 2024 | - | $268.74M(+133.7%) |
Jun 2024 | - | $114.97M(+1.3%) |
Mar 2024 | - | $113.53M(-1.6%) |
Dec 2023 | $115.36M(+41.1%) | $115.36M(+6.2%) |
Sep 2023 | - | $108.62M(+0.8%) |
Jun 2023 | - | $107.73M(+0.8%) |
Mar 2023 | - | $106.85M(+30.6%) |
Dec 2022 | $81.78M(+6.1%) | $81.78M(+1.0%) |
Sep 2022 | - | $80.96M(+2.1%) |
Jun 2022 | - | $79.31M(+1.7%) |
Mar 2022 | - | $77.99M(+1.2%) |
Dec 2021 | $77.09M(+311.4%) | $77.09M(+633.2%) |
Sep 2021 | - | $10.52M(-1.9%) |
Jun 2021 | - | $10.72M(-1.8%) |
Mar 2021 | - | $10.92M(-41.7%) |
Dec 2020 | $18.74M(-53.1%) | $18.74M(-26.6%) |
Sep 2020 | - | $25.53M(-22.3%) |
Jun 2020 | - | $32.86M(-18.0%) |
Mar 2020 | - | $40.08M(+0.3%) |
Dec 2019 | $39.95M(+92.8%) | $39.95M(+2.6%) |
Sep 2019 | - | $38.92M(+4.0%) |
Jun 2019 | - | $37.41M(+0.2%) |
Mar 2019 | - | $37.34M(+80.2%) |
Dec 2018 | $20.73M(+752.6%) | $20.73M(+767.9%) |
Sep 2018 | - | $2.39M(-0.5%) |
Jun 2018 | - | $2.40M(-0.7%) |
Mar 2018 | - | $2.42M(-0.6%) |
Dec 2017 | $2.43M(+19.4%) | $2.43M(-0.6%) |
Sep 2017 | - | $2.45M(-0.7%) |
Jun 2017 | - | $2.46M(-1.0%) |
Mar 2017 | - | $2.49M(+22.2%) |
Dec 2016 | $2.04M(+48.4%) | $2.04M(-0.8%) |
Sep 2016 | - | $2.05M(+3.7%) |
Jun 2016 | - | $1.98M(+14.7%) |
Mar 2016 | - | $1.72M(+25.6%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2015 | $1.37M(-10.0%) | $1.37M(-2.7%) |
Sep 2015 | - | $1.41M(-2.6%) |
Jun 2015 | - | $1.45M(-2.6%) |
Mar 2015 | - | $1.49M(-2.5%) |
Dec 2014 | $1.52M(-12.5%) | $1.52M(-2.4%) |
Sep 2014 | - | $1.56M(-2.4%) |
Jun 2014 | - | $1.60M(-8.8%) |
Mar 2014 | - | $1.75M(+0.7%) |
Dec 2013 | $1.74M(-59.6%) | $1.74M(-56.3%) |
Sep 2013 | - | $3.98M(-3.3%) |
Jun 2013 | - | $4.12M(-2.3%) |
Mar 2013 | - | $4.21M(-2.2%) |
Dec 2012 | $4.31M(+30.7%) | $4.31M(-1.7%) |
Sep 2012 | - | $4.38M(-0.3%) |
Jun 2012 | - | $4.40M(-5.8%) |
Mar 2012 | - | $4.66M(+41.6%) |
Dec 2011 | $3.29M(-84.1%) | $3.29M(-80.4%) |
Sep 2011 | - | $16.84M(+0.7%) |
Jun 2011 | - | $16.73M(+0.7%) |
Mar 2011 | - | $16.61M(-19.8%) |
Dec 2010 | $20.71M(+348.3%) | $20.71M(+0.7%) |
Sep 2010 | - | $20.56M(+0.6%) |
Jun 2010 | - | $20.45M(+0.3%) |
Mar 2010 | - | $20.40M(+341.6%) |
Dec 2009 | $4.62M(+11.6%) | $4.62M(-19.4%) |
Sep 2009 | - | $5.73M(+1.4%) |
Jun 2009 | - | $5.65M(+1.4%) |
Mar 2009 | - | $5.57M(+34.6%) |
Dec 2008 | $4.14M(>+9900.0%) | $4.14M(+40.3%) |
Sep 2008 | - | $2.95M(-0.1%) |
Jun 2008 | - | $2.95M(+810.4%) |
Jun 2005 | - | $324.40K(>+9900.0%) |
Dec 2000 | $0.00(-100.0%) | $0.00(-100.0%) |
Dec 1999 | $100.00K(-200.0%) | $100.00K(-133.3%) |
Mar 1999 | - | -$300.00K(+200.0%) |
Dec 1998 | -$100.00K | -$100.00K(0.0%) |
Jun 1997 | - | -$100.00K(-200.0%) |
Sep 1996 | - | $100.00K |
FAQ
- What is TG Therapeutics annual total long term liabilities?
- What is the all time high annual long term liabilities for TG Therapeutics?
- What is TG Therapeutics annual long term liabilities year-on-year change?
- What is TG Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for TG Therapeutics?
- What is TG Therapeutics quarterly long term liabilities year-on-year change?
What is TG Therapeutics annual total long term liabilities?
The current annual long term liabilities of TGTX is $264.65M
What is the all time high annual long term liabilities for TG Therapeutics?
TG Therapeutics all-time high annual total long term liabilities is $264.65M
What is TG Therapeutics annual long term liabilities year-on-year change?
Over the past year, TGTX annual total long term liabilities has changed by +$149.28M (+129.40%)
What is TG Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of TGTX is $259.19M
What is the all time high quarterly long term liabilities for TG Therapeutics?
TG Therapeutics all-time high quarterly total long term liabilities is $268.74M
What is TG Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, TGTX quarterly total long term liabilities has changed by +$145.66M (+128.30%)